Veteran dealmaker and operating executive focused on middle-market growth and value creation across technology and healthcare sectors. Robert Amato combines private equity investment experience with hands-on portfolio leadership, emphasizing EBITDA expansion, strategic M&A and operational improvements. Track record centers on board-level governance, commercial scaling and management team development; capital partners view him as a pragmatic operator who bridges investment strategy and execution.
Veteran dealmaker and operating executive focused on middle-market growth and value creation across technology and healthcare sectors. Robert Amato combines private equity investment experience with hands-on portfolio leadership, emphasizing EBITDA expansion, strategic M&A and operational improvements. Track record centers on board-level governance, commercial scaling and management team development; capital partners view him as a pragmatic operator who bridges investment strategy and execution.
Patient, operationally oriented private equity investor targeting middle-market technology and healthcare companies. Prioritizes control or influential minority positions where hands-on governance and management development can drive EBITDA expansion. Capital allocation emphasizes buy-and-build M&A, commercial scale-up and disciplined cost rationalization with a 3–7 year value-creation horizon. Risk framework blends conservative leverage, milestone-based capital deployment and active board engagement to align incentives and accelerate exit readiness.
Patient, operationally oriented private equity investor targeting middle-market technology and healthcare companies. Prioritizes control or influential minority positions where hands-on governance and management development can drive EBITDA expansion. Capital allocation emphasizes buy-and-build M&A, commercial scale-up and disciplined cost rationalization with a 3–7 year value-creation horizon. Risk framework blends conservative leverage, milestone-based capital deployment and active board engagement to align incentives and accelerate exit readiness.
| Trades 202 | Longs Won 144/202 71% | Profit Factor 9.25 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $411,742.25 |
| Average Win $198,163.24 | Best Trade (Jul 14) $5.76M | Sharpe Ratio -103.57 |
| Average Loss -$53,206.86 | Worst Trade (Jul 14) -$510,291.36 | Z-Score 6.52 (100%) |
| Commissions $0 | Avg. Trade Length 8m | Expectancy $125,987.67 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 4,566 | 4,110 | 3,653 | 3,196 | 2,740 | 2,283 | 1,826 | 1,370 | 913 | 457 |